Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies

Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies

<h4>Background</h4> <p>The efficacy of antipsychotics across the initial severity range in acute mania remains unclear. Therefore, we decided to examine the influence of baseline severity on the efficacy of olanzapine.</p> <h4>Methods</h4> <p> We conducted...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Samara, MT, Goldberg, Y, Levine, SZ, Furukawa, TA, Geddes, JR, Cipriani, A, Davis, JM, Leucht, S
Natura:	Journal article
Lingua:	English
Pubblicazione:	Elsevier 2017

Documenti analoghi

Initial Severity of Schizophrenia and Efficacy of Antipsychotics: Participant-Level Meta-analysis of 6 Placebo-Controlled Studies.
di: Furukawa, T, et al.
Pubblicazione: (2015)

Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil
di: Levine, SZ, et al.
Pubblicazione: (2022)

Olanzapine in long-term treatment for bipolar disorder.
di: Cipriani, A, et al.
Pubblicazione: (2009)

Olanzapine in long-term treatment for bipolar disorder
di: Cipriani, A, et al.
Pubblicazione: (2009)

Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?
di: Leucht, S, et al.
Pubblicazione: (2018)

Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician’s Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: evidence based on individual participant data from five randomized clinical trials of donepezil
di: Samara, M, et al.
Pubblicazione: (2021)

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
di: Leucht, S, et al.
Pubblicazione: (2018)

Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis.
di: Cipriani, A, et al.
Pubblicazione: (2010)

Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
di: Stephen Z. Levine, et al.
Pubblicazione: (2021-01-01)

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis
di: Leucht, S, et al.
Pubblicazione: (2019)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
di: Gao K, et al.
Pubblicazione: (2013-08-01)

Bipolar treatment efficacy Reply
di: Miura, T, et al.
Pubblicazione: (2014)

Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
di: Levine, SG, et al.
Pubblicazione: (2021)

Olanzapine discontinuation emergent recurrence in bipolar disorder
di: Manu Arora, et al.
Pubblicazione: (2014-01-01)

DSM-III-R change in definition might have affected placebo response to antidepressants - Authors' reply
di: Cipriani, A, et al.
Pubblicazione: (2017)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors.
di: Leucht, S, et al.
Pubblicazione: (2017)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors
di: Leucht, S, et al.
Pubblicazione: (2017)

Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta‐analysis
di: Furukawa, T, et al.
Pubblicazione: (2018)

Melatonin Decreases Olanzapine Induced Metabolic Side-Effects in Adolescents with Bipolar Disorder: a Randomized Double-Blind Placebo-Controlled Trial
di: Ali Mostafavi, et al.
Pubblicazione: (2014-10-01)

Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration
di: Zain, M.A., et al.
Pubblicazione: (2012)

Olanzapine-Induced Mania in Bipolar Spectrum Disorder:A Case Report
di: Mehrdad Eftekhar, et al.
Pubblicazione: (2006-09-01)

Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration
di: Zain Mohd, et al.
Pubblicazione: (2012-10-01)

Olanzapine-Induced Mania in Bipolar Spectrum Disorder:A Case Report
di: Mehrdad Eftekhar, et al.
Pubblicazione: (2006-07-01)

Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis
di: Miura, T, et al.
Pubblicazione: (2014)

Olanzapine alone or in combination for acute mania.
di: Rendell, J, et al.
Pubblicazione: (2003)

Prodromal symptoms may be identified by people with bipolar or unipolar depression.
di: Geddes, J
Pubblicazione: (2003)

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
di: Novick D, et al.
Pubblicazione: (2017-06-01)

Antidepressants for bipolar disorder: A clinical overview of efficacy and safety
di: Cipriani, A, et al.
Pubblicazione: (2008)

Shortening the Alzheimer’s disease assessment scale cognitive subscale
di: Stephen Z. Levine, et al.
Pubblicazione: (2024-01-01)

Olanzapine in Treatment of Patients With Bipolar 1 Disorder And Panic Comorbidity: A Case Study
di: Lilijana Oruč, et al.
Pubblicazione: (2003-11-01)

Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy.
di: Furukawa, T, et al.
Pubblicazione: (2018)

Memantine Enhances the Effect of Olanzapine in Patients With Schizophrenia: A Randomized, Placebo-Controlled Study
di: Ahmad Fakhri, et al.
Pubblicazione: (2016-12-01)

Authors' reply
di: Leucht, S, et al.
Pubblicazione: (2013)

Efficacy of antipsychotic drugs for schizophrenia - Authors' reply.
di: Leucht, S, et al.
Pubblicazione: (2013)

Olanzapine–valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese population group
di: Xu L, et al.
Pubblicazione: (2015-05-01)

Efficient two-step multivariate random effects meta-analysis of individual participant data for longitudinal clinical trials using mixed effects models
di: Hisashi Noma, et al.
Pubblicazione: (2019-02-01)

Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review
di: Furukawa, T, et al.
Pubblicazione: (2016)

Personalized prediction of Alzheimer's disease and its treatment effects by donepezil: an individual participant data meta-analysis of eight randomized controlled trials
di: Yoshida, K, et al.
Pubblicazione: (2022)

Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article
di: Chaimani, A, et al.
Pubblicazione: (2017)

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.
di: Geddes, J, et al.
Pubblicazione: (2009)